Skip Navigation LinksHome > February 1, 2011 - Volume 56 - Issue 2 > Pandemic (H1N1) 2009 Influenza Virus Seroconversion Rates in...
Text sizing:
A
A
A
JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/QAI.0b013e318204a1c3
Rapid Communication

Pandemic (H1N1) 2009 Influenza Virus Seroconversion Rates in HIV-Infected Individuals

Kok, Jen MBBS*; Tudo, Katherine BMedSci*; Blyth, Christopher C MBBS, FRACP, FRCPA†; Foo, Hong MBBS, FRACP, FRCPA‡; Hueston, Linda BSci, MSci*; Dwyer, Dominic E MD, FRACP, FRCPA*

Collapse Box

Abstract

The impact of pandemic (H1N1) 2009 influenza in HIV-infected individuals is unknown. Determining the prevalence of pandemic influenza in this at-risk group will guide vaccination programs. After the first pandemic wave, the seroprevalence rate of pandemic influenza in HIV-infected individuals in western Sydney, New South Wales, Australia, was 34.2%, similar to the rate observed in the general population. However, true seroprevalence is more accurately determined by seroconversion, defined as a 4-fold or greater rise between preexposure and postexposure antibody levels, which was 14.6% in the present study. Seroconversion rates were independent of CD4+ T-lymphocyte count and HIV plasma load. Neither HIV infection, nor severe immunosuppression, was a significant risk factor for pandemic influenza during the first southern hemisphere pandemic wave.

© 2011 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.